文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

淋巴结阳性对数优势在结直肠黏液腺癌预后评估中的价值:分析及外部验证。

Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation.

机构信息

Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Department of Colorectal Surgery, Fujian Medical University Union Hospital, Fuzhou, China.

出版信息

Cancer Med. 2021 Dec;10(23):8542-8557. doi: 10.1002/cam4.4366. Epub 2021 Nov 18.


DOI:10.1002/cam4.4366
PMID:34796687
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8633225/
Abstract

PURPOSE: To evaluate the impact of the log odds of positive lymph nodes (LODDS) on cancer-specific survival (CSS) in colon mucinous adenocarcinoma (MAC) patients, compared with pN stage and the lymph nodes ratio (LNR). METHODS: A total of 10,182 colon MAC patients from the Surveillance, Epidemiology, and End Results database were divided into the training group. The external validation group included 153 patients from Fujian Medical University Union Hospital. The Cox regression method was used to identify prognostic risk factors. Nomograms were evaluated by Harrell's concordance index (C-index) and calibration curves. Recursive partitioning analysis (RPA) was used to develop a novel staging system. RESULTS: Time-dependent receiver operating characteristic curves (ROC) to predict CSS showed the areas under the ROC curve of LODDS were always higher than pN stage and LNR. LNR and LODDS classifications can well distinguish the prognosis of patients with the same pN stage. Cox analyses indicated that age, tumor size, pT stage, pN stage, LNR, and LODDS were independent predictors of CSS (p < 0.05). Based on three lymph nodes classifications, we constructed three prognostic nomograms models for CSS. The C-index of the pN, LNR, and LODDS classification nomograms were 0.746 (95% confidence interval [95% CI]: 0.736-0.756), 0.750 (95% CI: 0.740-0.760), and 0.758 (95% CI: 0.748-0.768), respectively. In external validation, we observed the C-index of LODDS classification nomograms was 0.787 (95% CI: 0.648-0.926). RPA stage, including four stages, was constructed successfully based on pT stage and LNR or LODDS, respectively. The 3-, 5-, and 8-year areas under the ROC curve of LNR-RPA stage and LODDS-RPA stage were superior to tumor-node-metastasis stage. CONCLUSION: LODDS to be a better prognostic factor of CSS for colon MAC patients than pN stage and LNR. A nomogram and RPA stage base on LODDS can provide accurate information for personalized cancer treatment.

摘要

目的:评估对数阳性淋巴结(LODDS)对结直肠黏液腺癌(MAC)患者癌症特异性生存(CSS)的影响,与 pN 分期和淋巴结比率(LNR)相比。

方法:从监测、流行病学和最终结果(SEER)数据库中选取 10182 例结直肠 MAC 患者作为训练组。外部验证组包括来自福建医科大学附属协和医院的 153 例患者。使用 Cox 回归方法识别预后危险因素。通过 Harrell 一致性指数(C 指数)和校准曲线评估列线图。递归分区分析(RPA)用于开发新的分期系统。

结果:时间依赖性接受者操作特征曲线(ROC)预测 CSS 的结果显示,LODDS 的 ROC 曲线下面积始终高于 pN 分期和 LNR。LNR 和 LODDS 分类可以很好地区分具有相同 pN 分期的患者的预后。Cox 分析表明,年龄、肿瘤大小、pT 分期、pN 分期、LNR 和 LODDS 是 CSS 的独立预测因素(p<0.05)。基于三个淋巴结分类,我们构建了三个用于 CSS 的预后列线图模型。pN、LNR 和 LODDS 分类列线图的 C 指数分别为 0.746(95%置信区间[95%CI]:0.736-0.756)、0.750(95%CI:0.740-0.760)和 0.758(95%CI:0.748-0.768)。在外部验证中,我们观察到 LODDS 分类列线图的 C 指数为 0.787(95%CI:0.648-0.926)。基于 pT 分期和 LNR 或 LODDS,成功构建了包括四个阶段的 RPA 分期。LNR-RPA 分期和 LODDS-RPA 分期的 3、5 和 8 年 ROC 曲线下面积均优于肿瘤-淋巴结-转移(TNM)分期。

结论:LODDS 是结直肠 MAC 患者 CSS 的比 pN 分期和 LNR 更好的预后因素。基于 LODDS 的列线图和 RPA 分期可为个性化癌症治疗提供准确信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/cf2debb8c5cc/CAM4-10-8542-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/f45812e978d1/CAM4-10-8542-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/54979f7c4e31/CAM4-10-8542-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/fdfb731c3a75/CAM4-10-8542-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/888d00adff29/CAM4-10-8542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/b7e228ad63dc/CAM4-10-8542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/712539d00039/CAM4-10-8542-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/ba83799ce181/CAM4-10-8542-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/94c9598614c3/CAM4-10-8542-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/cf2debb8c5cc/CAM4-10-8542-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/f45812e978d1/CAM4-10-8542-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/54979f7c4e31/CAM4-10-8542-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/fdfb731c3a75/CAM4-10-8542-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/888d00adff29/CAM4-10-8542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/b7e228ad63dc/CAM4-10-8542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/712539d00039/CAM4-10-8542-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/ba83799ce181/CAM4-10-8542-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/94c9598614c3/CAM4-10-8542-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55ad/8633225/cf2debb8c5cc/CAM4-10-8542-g003.jpg

相似文献

[1]
Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation.

Cancer Med. 2021-12

[2]
Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.

BMC Cancer. 2021-8-4

[3]
Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.

Cancer Med. 2023-3

[4]
Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy.

Tumour Biol. 2016-8

[5]
Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.

Pancreatology. 2014

[6]
The prognostic impact of the log odds of positive lymph nodes in colon cancer.

Colorectal Dis. 2014-11

[7]
A Prognostic Model Based on the Log Odds Ratio of Positive Lymph Nodes Predicts Prognosis of Patients with Rectal Cancer.

J Gastrointest Cancer. 2024-9

[8]
Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes.

Eur J Surg Oncol. 2022-5

[9]
Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database.

Int J Surg. 2016-6-15

[10]
The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.

Asia Pac J Clin Oncol. 2021-4

引用本文的文献

[1]
Developing a novel model for predicting overall survival in late-onset colon adenocarcinoma patients based on LODDS: a study based on the SEER database and external validation.

Discov Oncol. 2025-1-29

[2]
Prediction values of different lymph nodes staging systems for survival of children with Wilms tumor.

Transl Cancer Res. 2024-12-31

[3]
A log odds of positive lymph nodes-based predictive model effectively forecasts prognosis and guides postoperative adjuvant chemotherapy duration in stage III colon cancer: a multi-center retrospective cohort study.

BMC Cancer. 2024-9-2

[4]
Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.

BMC Med Res Methodol. 2024-4-18

[5]
Log odds of positive lymph nodes show better predictive performance on the prognosis of early-onset colorectal cancer.

Int J Colorectal Dis. 2023-7-11

[6]
A Nomogram Based on the Log Odds of Positive Lymph Nodes Predicts the Prognosis of Patients with Colon Neuroendocrine Tumors After Surgery: A Surveillance, Epidemiology, and End Results Population-Based Study.

Technol Cancer Res Treat. 2023

[7]
Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis.

Radiat Oncol. 2023-1-21

[8]
Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.

Cancer Med. 2023-3

[9]
Establishment and validation of a postoperative predictive model for patients with colorectal mucinous adenocarcinoma.

World J Surg Oncol. 2022-10-3

[10]
Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis.

Front Oncol. 2022-3-17

本文引用的文献

[1]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[2]
Clinicopathological, molecular features and prognosis of colorectal cancer with mucinous component.

Future Oncol. 2021-4

[3]
autoRPA: A web server for constructing cancer staging models by recursive partitioning analysis.

Comput Struct Biotechnol J. 2020-11-10

[4]
Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study.

Transl Lung Cancer Res. 2020-8

[5]
Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer.

BMC Cancer. 2020-8-14

[6]
Prognostic value of log odds of positive lymph nodes in patients with resectable oral squamous cell carcinoma.

Oral Oncol. 2020-9

[7]
Colorectal cancer statistics, 2020.

CA Cancer J Clin. 2020-3-5

[8]
Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.

Anticancer Res. 2020-3

[9]
Tumor clinicopathological characteristics and their prognostic value in mucinous colorectal carcinoma.

Future Oncol. 2019-11-27

[10]
Mucinous colorectal adenocarcinoma: clinical pathology and treatment options.

Cancer Commun (Lond). 2019-3-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索